Skip to main content
Toggle Menu of ADA WebSites
ADA Websites
Toggle Search Area
Toggle Menu

FAQ: EPA Final Rule on Hazardous Waste Pharmaceuticals

Issues in the News
FAQ: EPA Final Rule on Hazardous Waste Pharmaceuticals banner image

Effective August 21, 2019, healthcare facilities and other businesses that generate pharmaceutical hazardous waste are required to manage those products according to the provisions of the Environmental Protection Agency’s (EPA) Management Standards for Hazardous Waste Pharmaceuticals (HWP) and Amendment to the P075 Listing for Nicotine Final Rule.

Disclaimer: These materials are intended to provide helpful information to dentists and dental team members. They are in no way a substitute for actual professional advice based upon your unique facts and circumstances. This content is not intended or offered, nor should it be taken, as legal or other professional advice. You should always consult with your own professional advisors (e.g. attorney, accountant, insurance carrier). To the extent ADA has included links to any third party web site(s), ADA intends no endorsement of their content and implies no affiliation with the organizations that provide their content. Further, ADA makes no representations or warranties about the information provided on those sites.

  • Why did the EPA update the Hazardous Waste Pharmaceutical Rule?
  • Does the Final Rule apply to dental practices?
  • Which pharmaceuticals are considered hazardous waste under the Final Rule?
  • How does the Final Rule define “pharmaceuticals?” Are dental amalgam or sharps included?
  • What does my practice need to do to comply with the Final Rule?
  • Are there penalties for non-compliance?
  • Does the Final Rule impact hazardous waste pharmaceuticals that the practice disposes of via reverse distributors?
  • Resources